Novo
Novo Nordisk shares jump almost 8% after US approves Wegovy pill
The approval gives the drugmaker a first-mover advantage in the race for a potent oral weight-loss medicine [COPENHAGEN/LONDON] Novo Nordisk shares jumped nearly 8 per cent on Tuesday (Dec...
Wegovy-maker Novo Nordisk to cut 9,000 jobs in restructuring
[COPENHAGEN] Wegovy-maker Novo Nordisk will cut 9,000 jobs, or about 11.5 per cent of its workforce, in a restructuring to save eight billion Danish crowns (S$1.6 billion) annually, it...
Novo Nordisk overtakes SAP as Europe’s most valuable company
Published Fri, Jun 13, 2025 · 05:38 PM[COPENHAGEN] Novo Nordisk reclaimed its position as Europe’s most valuable public company, overtaking software developer SAP. Shares in the Danish drugmaker climbed as...
Novo Nordisk latest drugmaker to drop gender goals in US
This follows executive orders by President Donald Trump to stop diversity, equity and inclusion initiativesPublished Wed, May 7, 2025 · 06:55 PM[COPENHAGEN] Obesity drugmaker Novo Nordisk said on Wednesday...
Novo seeks US$830 million from Singapore firm, accusing it of fraud over drug
Novo Nordisk is seeking as much as US$830 million in damages in a Singapore court, saying it was misled by a local biotech about the effectiveness of an experimental...
Singaporean Huang Zhenhua’s assets frozen over US$830 million suit by drug giant Novo
Novo Nordisk is seeking as much as US$830 million in damages in a Singapore court, saying that it was misled by a local biotech firm about the effectiveness of...
Singapore court freezes worldwide assets in US$830 million Novo Nordisk suit
The Danish drugmaker alleges misrepresentations by biotech firm founder Huang Zhenhua about the success of its kidney drug PHARMA giant Novo Nordisk has been granted an injunction by the...
Singapore court freezes worldwide assets in Novo Nordisk suit, including US$218m in DBS account
The Danish drugmaker alleges misrepresentations by biotech firm founder Huang Zhenhua about the success of its kidney drug PHARMA giant Novo Nordisk has been granted an injunction by the...